KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Gsk (GSK) Enterprise Value (2016 - 2025)

Gsk (GSK) has 7 years of Enterprise Value data on record, last reported at -$3.8 billion in Q4 2023.

  • For Q4 2023, Enterprise Value rose 17.09% year-over-year to -$3.8 billion; the TTM value through Dec 2023 reached -$3.8 billion, up 17.09%, while the annual FY2023 figure was -$3.8 billion, 21.25% up from the prior year.
  • Enterprise Value reached -$3.8 billion in Q4 2023 per GSK's latest filing, up from -$4.6 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$3.8 billion in Q4 2023 and bottomed at -$8.3 billion in Q4 2020.
  • Average Enterprise Value over 4 years is -$5.8 billion, with a median of -$5.6 billion recorded in 2019.
  • Peak YoY movement for Enterprise Value: decreased 29.46% in 2019, then increased 17.09% in 2023.
  • A 4-year view of Enterprise Value shows it stood at -$6.6 billion in 2019, then fell by 26.01% to -$8.3 billion in 2020, then skyrocketed by 44.76% to -$4.6 billion in 2022, then rose by 17.09% to -$3.8 billion in 2023.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$3.8 billion in Q4 2023, -$4.6 billion in Q4 2022, and -$8.3 billion in Q4 2020.